Absorbed radiation dose to humans from technetium-99m-teboroxime release_cza3okeec5bm5lpsl34lomepuq

by R K Narra, T Feld, A D Nunn

Published in Journal of Nuclear Medicine.

1992   Volume 33, Issue 1, p88-93

Abstract

Tissue distribution data obtained in nine normal volunteers were used to estimate the radiation dose to humans after intravenous administration of 99mTc-teboroxime (Cardiotec). Organ uptake as percent of injected dose was measured using quantitative SPECT. Non-linear regression analysis was performed on the organ time-activity data using SYSTAT software. Cumulative activities in these organs were determined by calculating the area under the respective curves after accounting for the physical decay of the radionuclide. The absorbed dose to individual organs was estimated using the MIRDOSE 2 program. The gallbladder and the upper large intestine (ULI) are the target organs and will receive respectively 26.5 and 33.2 muGy/MBq (98 and 123 mrad/mCi) 99mTc-teboroxime under the assumption that the gallbladder empties every 6 hr. The dose to the gallbladder decreases at shorter emptying intervals; with intervals of 3, 4, and 5 hr, the respective doses to the gallbladder are 18.2, 21.0 and 23.7 muGy/MBq (67.4, 77.8, and 87.9 mrad/mCi) 99mTc-teboroxime. However, the dose to ULI remains almost constant at 123 mrad/mCi and will be the limiting factor.
In text/plain format

Archived Files and Locations

application/pdf  1.1 MB
file_m4lupnieerdehceald4vml43cu
jnm.snmjournals.org (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   1992
Language   en ?
PubMed  1731003
Journal Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0161-5505
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 58d2d717-b7dd-4d39-ac3d-3e388e4ff9a3
API URL: JSON